Kerrin M. Green, MA, Assistant Managing Editor, JNCCN—Journal of the National Comprehensive Cancer Network
Ms. Green has disclosed that she has no relevant financial relationships.
Deborah J. Moonan, RN, BSN, Manager, CE Supporter Outreach
Ms. Moonan has disclosed the following relationship with commercial interests: AstraZeneca: Stockholder/Former Employee.
Nicole B. Harrold, BS, Manager, Continuing Education and Grants
Ms. Harrold has disclosed that she has no relevant financial relationships.
Kristina M. Gregory, RN, MSN, OCN, Vice President, Clinical Information Operations
Ms. Gregory has disclosed that she has no relevant financial relationships.
Cancer Facts & Figures 2013. American Cancer Society Web site. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed September 19, 2013.
Donadon M, Ribero D, Morris-Stiff G et al.. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 2007;1:20–27.
Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586–589.
Charnsangavej C, Clary B, Fong Y et al.. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1261–1268.
Pawlik TM, Scoggins CR, Zorzi D et al.. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715–722.
Adam R, Miller R, Pitombo M et al.. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 2007;16:525-536, viii.
Tsai MS, Su YH, Ho MC et al.. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 2007;14:786–794.
Adam R, Delvart V, Pascal G et al.. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644–657.
Folprecht G, Gruenberger T, Bechstein WO et al.. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 2010;11:38–47.
Okines A, Puerto OD, Cunningham D et al.. Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer 2009;101:1033–1038.
Benson AB III, Bekaii-Saab T, Chan E. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 4, 2013. Available at: NCCN.org. Accessed May 25, 2013.
Bartlett DL, Berlin J, Lauwers GY et al.. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1284–1292.
Mulcahy MF, Lewandowski RJ, Ibrahim SM et al.. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009;115:1849–1858.
Hendlisz A, Van den Eynde M, Peeters M et al.. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol 2010;28:3687–3694.
- Search Google Scholar
- Export Citation
. Hendlisz A Van den Eynde M Peeters M Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol 2010; 28: 3687– 3694.
Pawlik TM, Olino K, Gleisner AL et al.. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11:860–868.
Vauthey JN, Pawlik TM, Ribero D et al.. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065–2072.
Abdalla EK, Adam R, Bilchik AJ et al.. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271–1280.
Benson AB III, Bekaii-Saab T, Chan E et al.. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013;11:141–152; quiz 152.
Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al.. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–1223.